Coleen Glessner is EVP, Quality & Ethics, and CPL of Emergent BioSolutions Inc.. Currently has a direct ownership of 163,134 shares of EBS, which is worth approximately $1.55 Million. The most recent transaction as insider was on Jun 08, 2024, when has been sold 1,249 shares (Common Stock) at a price of $6.19 per share, resulting in proceeds of $7,731. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
1.34% 12M change
Total Value Held $1.55 Million

Coleen Glessner Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2024
SELL
Payment of exercise price or tax liability
$7,731 $6.19 p/Share
1,249 Reduced 0.76%
163,134 Common Stock
Apr 07 2024
SELL
Payment of exercise price or tax liability
$1,339 $2.29 p/Share
585 Reduced 0.35%
164,383 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$1,291 $3.39 p/Share
381 Reduced 0.23%
164,968 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
46,155 Added 21.82%
165,349 Common Stock
Apr 07 2023
BUY
Payment of exercise price or tax liability
-
480 Added 0.4%
120,154 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
11,538 Added 8.79%
119,674 Common Stock
Dec 09 2022
BUY
Grant, award, or other acquisition
-
96,310 Added 47.11%
108,136 Common Stock
Apr 08 2022
BUY
Grant, award, or other acquisition
-
11,826 Added 50.0%
11,826 Common Stock
CG

Coleen Glessner

EVP, Quality & Ethics, and CPL
Gaithersburg, MD

Track Institutional and Insider Activities on EBS

Follow Emergent BioSolutions Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EBS shares.

Notify only if

Insider Trading

Get notified when an Emergent Bio Solutions Inc. insider buys or sells EBS shares.

Notify only if

News

Receive news related to Emergent BioSolutions Inc.

Track Activities on EBS